BCV
BLRX

Banque Cantonale Vaudoise’s BioLineRX BLRX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
1
– – ﹤0.01% 436
2026
Q1 		$0 Hold
1
– – ﹤0.01% 877
2025
Q4 		$0 Buy
+1
New +$3 ﹤0.01% 824

Other funds holding BLRX

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Banque Cantonale Vaudoise's BLRX Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its BioLineRX (BLRX) position steady in Q2 2026 at 1 share worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Banque Cantonale Vaudoise first reported a position in BLRX in Q4 2025 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold BLRX as of Q2 2026.

  • Banque Cantonale Vaudoise held 1 share of BioLineRX worth $1K as of Q2 2026.
  • Banque Cantonale Vaudoise left its BioLineRX share count unchanged in Q2 2026.
  • BioLineRX made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #436 holding.
  • Banque Cantonale Vaudoise first reported a position in BioLineRX in Q4 2025 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held BioLineRX as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.